期刊文献+

微粒化非诺贝特对原发性高血压颈动脉内膜中层厚度与脑血流动力学的影响 被引量:7

Effects of Micronised Fenofibrate on Carotid Artery Intima-media thickness and Cerebrovascular Hemodynamics in Essential Hypertension
下载PDF
导出
摘要 目的 探讨微粒化非诺贝特对原发性高血压患者颈动脉内膜中层厚度 (IMT)与脑循环动力学 (CVA)的影响。方法 分别对 2 0 7例原发性高血压患者应用微粒化非诺贝特进行为期 2 4个月的治疗和对照 ,观察治疗前后患者颈动脉超声、脑循环动力学及血脂等指标的变化。结果 治疗组 2 4个月后颈动脉IMT基本保持稳定 ,IMT/内径 (D)比率及颈动脉粥样硬化斑块发生率均比治疗前有明显降低 (P <0 0 5 ) ;脑循环动力学指标较治疗前明显改善。结论 在有效降压治疗的同时加用微粒化非诺贝特治疗 ,对原发性高血压患者延缓颈动脉粥样硬化的进展和改善脑循环动力学有良好效果。 Objective To investigate the effects of micronised fenofibrate treatment on carotid artery intima-media thickness (IMT) and cerebrovascular hemodynamics(CVA)in patients with essential hypertension. Methods Carotid artery was examed using color-Dopler ultrasonography. CVA and the levels of serum lipids were measured in 207 cases of essential hypertension before and after the treatment. The Patients were assigned to receive micronised fenofibrate(200 mg/d,n =102) in combination with conventional anti-hypertensive treatment or anti-hypertensive treatment alone( n =105)for 24 months. Results The IMT of carotid artery was little change in micronised fenofibrate combined group after treatment. The IMT/D ratio and the incidence of the carotid arteriosclerosis plaque were reduced and the CVA was improved significantly in combined treatment group than that of control after the treatment. Conclusion The carotid arteriosclerosis in essential hyertension was prevented and the CVA be effectively improved by micronised fenofibrate when the patients blood pressure were controlled.
出处 《高血压杂志》 CSCD 2004年第1期12-16,共5页 Chinese Journal of Hypertension
基金 济南市科技局研究基金资助 (济科合字 [2 0 0 0 ]第 1 2 2号
关键词 微粒化非诺贝特 颈动脉 内膜中层厚度 脑血管循环 原发性高血压 脑血流动力学 micronised fenofibrate carotid artery intima-media thickness cerebrovascular circulation hypertension
  • 相关文献

参考文献6

  • 1Yatsu FM, Zivin J. Hypertension in acute ischemic strokes: not to treat[J].Arch Neuro,1998,42:996-1008.
  • 2Guinness C, Seccombe DW, Frohlich J, et al. Laboratory standardization of a large international clinical trial:the DAIS experience[J].Clin Biochem,2000,33:15-24.
  • 3Hedera P,Budakova J. Stroke risk factors and development of collateral occlusive disease[J].ActaNeurol Scand,1998,98:182-186.
  • 4李晓红,刘希汉,朱世明,邴淑丽,侯保兴.急性脑梗塞超早期脑循环动力学改变与CT对比研究[J].山东医科大学学报,2000,38(1):72-75. 被引量:2
  • 5Laakso M, Lehtos P. Lipids and lipoproteins predicting coronary heart disease mortaliy and mobidity in patient with NIDD[J].Clin Girculation,1998,1421-1430.
  • 6Haffner SM. The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease[J].Endocrine Rev,1998,19:583-592.

二级参考文献2

共引文献1

同被引文献51

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部